Mirum Pharmaceuticals, Inc. announced that on April 10, 2024, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 36,100 shares of common stock and 18,050 restricted stock units to nine new employees under Mirum’s 2020 Inducement Plan.
